(Q46599065)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16015372%20AND%20SRC:MED&resulttype=core&format=json

30 December 2019

meta-analysis

0 references

title

Selective serotonin reuptake inhibitor (SSRI) use during pregnancy and effects on the fetus and newborn: a meta-analysis (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16015372%20AND%20SRC:MED&resulttype=core&format=json

30 December 2019

1 reference

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16015372%20AND%20SRC:MED&resulttype=core&format=json

30 December 2019

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16015372%20AND%20SRC:MED&resulttype=core&format=json

30 December 2019

Keri A Lattimore

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16015372%20AND%20SRC:MED&resulttype=core&format=json

30 December 2019

Steven M Donn

series ordinal

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16015372%20AND%20SRC:MED&resulttype=core&format=json

30 December 2019

Alex R Kemper

series ordinal

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16015372%20AND%20SRC:MED&resulttype=core&format=json

30 December 2019

Charles R Neal

series ordinal

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16015372%20AND%20SRC:MED&resulttype=core&format=json

30 December 2019

publication date

1 September 2005

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16015372%20AND%20SRC:MED&resulttype=core&format=json

30 December 2019

published in

Journal of Perinatology

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16015372%20AND%20SRC:MED&resulttype=core&format=json

30 December 2019

volume

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16015372%20AND%20SRC:MED&resulttype=core&format=json

30 December 2019

issue

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16015372%20AND%20SRC:MED&resulttype=core&format=json

30 December 2019

page(s)

595-604

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16015372%20AND%20SRC:MED&resulttype=core&format=json

Comparing age at onset of major depression and other psychiatric disorders by birth cohorts in five US community populations

30 December 2019

cites work

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JP.7211352

Lifetime and 12-month prevalence of DSM-III-R psychiatric disorders in the United States. Results from the National Comorbidity Survey

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JP.7211352

Depressive symptoms among pregnant women screened in obstetrics settings

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JP.7211352

Obstetric complications in patients with depression--a population-based case-control study

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JP.7211352

Role of anxiety and depression in the onset of spontaneous preterm labor

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JP.7211352

Maternal prenatal depressive symptoms and spontaneous preterm births among African-American women in Baltimore, Maryland

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JP.7211352

Depressive symptomatology during pregnancy: evidence for an association with decreased fetal growth in pregnancies of lower social class women

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JP.7211352

Role of selective serotonin reuptake inhibitors in psychiatric disorders: a comprehensive review

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JP.7211352

Serotonin as a developmental signal

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JP.7211352

Structural effects and neurofunctional sequelae of developmental exposure to psychotherapeutic drugs: experimental and clinical aspects

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JP.7211352

Serotonin transporter messenger RNA expression in neural crest-derived structures and sensory pathways of the developing rat embryo

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JP.7211352

Peripheral and central neurochemical effects of the selective serotonin reuptake inhibitors (SSRIs) in humans and nonhuman primates: assessing bioeffect and mechanisms of action

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JP.7211352

Safety of fluoxetine during the first trimester of pregnancy: a meta-analytical review of epidemiological studies.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JP.7211352

Transplacental transfer of citalopram, fluoxetine and their primary demethylated metabolites in isolated perfused human placenta

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JP.7211352

Placental passage of antidepressant medications

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JP.7211352

Citalopram in pregnancy and lactation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JP.7211352

Neonatal paroxetine withdrawal syndrome or actually serotonin syndrome?

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JP.7211352

Antidepressant discontinuation syndromes

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JP.7211352

21 January 2018

The serotonin syndrome

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JP.7211352

Neonate characteristics after maternal use of antidepressants in late pregnancy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JP.7211352

Outcomes of prenatal antidepressant exposure

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JP.7211352

Delivery outcome after the use of antidepressants in early pregnancy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JP.7211352

The impact of depression and fluoxetine treatment on obstetrical outcome

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JP.7211352

Maternal selective serotonin reuptake inhibitor use during pregnancy and newborn neurobehavior

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JP.7211352

Birth outcomes after prenatal exposure to antidepressant medication

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JP.7211352

Child development following exposure to tricyclic antidepressants or fluoxetine throughout fetal life: a prospective, controlled study

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JP.7211352

Pregnancy outcome following maternal use of the new selective serotonin reuptake inhibitors: a prospective controlled multicenter study

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JP.7211352

Neurodevelopment of children exposed in utero to antidepressant drugs

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JP.7211352

Pregnancy outcome following first-trimester exposure to fluoxetine (Prozac)

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JP.7211352

Perinatal outcome following third trimester exposure to paroxetine

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JP.7211352

Follow-up of children of depressed mothers exposed or not exposed to antidepressant drugs during pregnancy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JP.7211352

Effects of first-trimester fluoxetine exposure on the newborn

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JP.7211352

Pregnancy outcome following gestational exposure to venlafaxine: a multicenter prospective controlled study

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JP.7211352

Effects of exposure to selective serotonin reuptake inhibitors during pregnancy on serotonergic symptoms in newborns and cord blood monoamine and prolactin concentrations

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JP.7211352

Pooled analysis of antidepressant levels in lactating mothers, breast milk, and nursing infants

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JP.7211352

Fluoxetine and norfluoxetine concentrations in nursing infants and breast milk

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JP.7211352

The Pharmacokinetics of Sertraline Excretion Into Human Breast Milk

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JP.7211352

Pharmacokinetics of fluoxetine and norfluoxetine in pregnancy and lactation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JP.7211352

Weight gain in infants breastfed by mothers who take fluoxetine.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JP.7211352

Prolonged prenatal psychotropic medication exposure alters neonatal acute pain response.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JP.7211352

Paroxetine use throughout pregnancy: does it pose any risk to the neonate?

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JP.7211352

Placental transfer and fetal distribution of fluoxetine in the rat

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JP.7211352

7 January 2021

Birth outcomes in pregnant women taking fluoxetine

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JP.7211352

7 January 2021

Pharmacologic factors associated with transient neonatal symptoms following prenatal psychotropic medication exposure.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JP.7211352

7 January 2021

Effects of third trimester fluoxetine exposure on the newborn

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JP.7211352

7 January 2021

Birth outcomes following prenatal exposure to fluoxetine

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JP.7211352

7 January 2021

Breastfeeding during maternal antidepressant treatment with serotonin reuptake inhibitors: infant exposure, clinical symptoms, and cytochrome p450 genotypes.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JP.7211352

7 January 2021